Clinical Trial Update: HR021618 in Moderate to Severe Pain After Abdominal Surgery [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial of HR021618 for moderate to severe postoperative pain after abdominal surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• HR021618

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Pain After Abdominal Surgery | Phase 2 | Status: COMPLETED